Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
Apply
Avutometinib, Defactinib, Everolimus
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step